Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Lozisoft
- Development stage
- Unknown
- Lead developer
- Canixa Life Sciences
- Administration
- Topical
01
Overview
Lozisoft is a topical emollient formulation developed by Canixa Life Sciences, available as a cream and lotion. It contains a combination of white soft paraffin, light liquid paraffin, and aloe vera gel. Lozisoft works by forming an occlusive layer of oil on the skin's surface, which prevents the evaporation of water and helps restore the skin's natural lipid barrier. This action increases the water content of the stratum corneum, soothing dry, irritated, and cracked skin. It is approved and widely used for the management of dry skin conditions, including atopic dermatitis, eczema, psoriasis, and ichthyosis.
- Brand names
- Lozisoft
Beyond the preview
Go deeper on Lozisoft.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Lozisoft.